Investigating the gene and gene expression differences in the cells that drive leukemia development and relapse in children with AML [ 2013 - ]

Research Grant

Researchers: Dr Elizabeth Kruse (Principal investigator)

Brief description Current treatments for AML are initially effective at killing the majority of leukemic cells, but the disease often comes back (relapses) due to rare cells that escape treatment and can regenerate the cancer (called leukemic stem cells or LSC for short). This project aims to determine if an individual patient has one, or many kinds of LSC and which kind of LSC is most likely to cause relapse. We believe that this knowledge will lead to new treatments that can target the cells that cause relapse.

Funding Amount $388,612.00

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF